The Enterprise Value as of September 2024 (TTM) for Crinetics Pharmaceuticals, Inc. (CRNX) is 4.08B

According to Crinetics Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.08B. This represents a change of 56.93% compared to the average of 2.60B of the last 4 quarters.

Crinetics Pharmaceuticals, Inc. (CRNX) Historical Enterprise Value (quarterly & annually)

How has CRNX Enterprise Value performed in the past?

The mean historical Enterprise Value of Crinetics Pharmaceuticals, Inc. over the last ten years is 720.37M. The current 4.08B Enterprise Value has changed 56.52% with respect to the historical average. Over the past ten years (40 quarters), CRNX's Enterprise Value was at its highest in in the June 2024 quarter at 3.39B. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.

Crinetics Pharmaceuticals, Inc. (CRNX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Crinetics Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Crinetics Pharmaceuticals, Inc. (CRNX) Average Enterprise Value

How has CRNX Enterprise Value performed in the past?

The current Enterprise Value of Crinetics Pharmaceuticals, Inc. (CRNX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Crinetics Pharmaceuticals, Inc. (CRNX) Enterprise Value vs. Peers

How is CRNX’s Enterprise Value compared to its peers?

Crinetics Pharmaceuticals, Inc.’s Enterprise Value is greater than Viridian Therapeutics, Inc. (1.29B), less than Cytokinetics, Incorporated (7.26B), greater than Structure Therapeutics Inc. (1.93B), greater than Icosavax, Inc. (713.87M), less than Passage Bio, Inc. (0), greater than REGENXBIO Inc. (47.09M), greater than LianBio (728.62M), greater than Kezar Life Sciences, Inc. (-66141903.00), greater than Inhibrx, Inc. (30.94M), greater than Merus N.V. (30.67M), greater than Lyell Immunopharma, Inc. (2.79B), greater than Kronos Bio, Inc. (234.00M), greater than Black Diamond Therapeutics, Inc. (12.94M), greater than TCR2 Therapeutics Inc. (302.60M), greater than Harpoon Therapeutics, Inc. (49.64M), greater than Alector, Inc. (861.85M), greater than null (554.49M),

Build a custom stock screener for Crinetics Pharmaceuticals, Inc. (CRNX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Crinetics Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Crinetics Pharmaceuticals, Inc. (CRNX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Crinetics Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.